WASHINGTON — Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its lifesaving EpiPen as a generic drug and qualified for lower rebate payments to states. The chairman of the Senate Judiciary Committee, Sen. Charles Grassley, R-Iowa, and Democratic Sens. Under the Medicaid...